Clinical Trials Browser

Phase 2 × Adenocarcinoma × Axitinib × Clear all

NCT00600821 2013-11-08

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Phase 2 Completed

118 enrolled 12 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung